These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20407451)

  • 61. Amgen's big-ticket play for Immunex.
    Fletcher L
    Nat Biotechnol; 2002 Feb; 20(2):105-6. PubMed ID: 11821840
    [No Abstract]   [Full Text] [Related]  

  • 62. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV
    Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
    [No Abstract]   [Full Text] [Related]  

  • 63. Nurturing European collaboration.
    Nat Rev Drug Discov; 2008 Jul; 7(7):548-9. PubMed ID: 18591973
    [No Abstract]   [Full Text] [Related]  

  • 64. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Millennium and Aventis in unique pact.
    Fletcher L
    Nat Biotechnol; 2000 Aug; 18(8):817. PubMed ID: 10932140
    [No Abstract]   [Full Text] [Related]  

  • 66. An Indian effort towards affordable drugs: "generic to designer drugs".
    Taneja B; Yadav J; Chakraborty TK; Brahmachari SK
    Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440
    [No Abstract]   [Full Text] [Related]  

  • 67. Ban on publishing industry funded research could harm surgical innovation.
    Chapman S; Bhangu A
    BMJ; 2014 Feb; 348():g1291. PubMed ID: 24500350
    [No Abstract]   [Full Text] [Related]  

  • 68. Collaboration studies co-receptor drug research.
    AIDS Patient Care STDS; 1998 Mar; 12(3):230. PubMed ID: 11361940
    [No Abstract]   [Full Text] [Related]  

  • 69. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Follow-on drugs and indications: the importance of incremental innovation to medical practice.
    Cohen J; Kaitin K
    Am J Ther; 2008; 15(1):89-91. PubMed ID: 18223359
    [No Abstract]   [Full Text] [Related]  

  • 71. [What is the fair price of innovative therapy?].
    Fischer A; Dewatripont M; Goldman M
    Med Sci (Paris); 2020 Apr; 36(4):389-393. PubMed ID: 32356716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does health care reform require killing managed competition?
    Telling FW
    Clin Perform Qual Health Care; 1994; 2(1):40-1. PubMed ID: 10135443
    [No Abstract]   [Full Text] [Related]  

  • 74. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 75. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 76. Disease management. Getting out from under drug companies' shadows.
    Heimoff S
    Manag Care; 2000 Mar; 9(3):39-40, 42-3. PubMed ID: 11066212
    [No Abstract]   [Full Text] [Related]  

  • 77. Merck wipes Serono off Swiss biotech map.
    Urquhart L
    Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharma now needs more than mergers.
    Wiggins P
    Expert Opin Investig Drugs; 2004 Feb; 13(2):93-5. PubMed ID: 14996644
    [No Abstract]   [Full Text] [Related]  

  • 79. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
    Avanzini G; Engel J
    Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.